Skip to search formSkip to main contentSkip to account menu

CVT 510

Known as: CVT-510 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

tecadenoson

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Electrophysiologic Disorders Termination of Paroxysmal Supraventricular Tachycardia by Tecadenoson ( CVT-510 ) , a Novel A 1-Adenosine Receptor Agonist
Termination of Paroxysmal Supraventricular Tachycardia by Tecadenoson (CVT-510), a Novel A1-Adenosine Receptor Agonist Eric N… 
2010
2010
INO-8875, a Highly-Selective A1 Adenosine Receptor Agonist: Evaluation of Chronotropic, Dromotropic and Hemodynamic Effects in Rats.
Publication of this article is suspended until the authors can provide full identification and verification of the chemical… 
2003
2003
N-[3-(R)-Tetrahydrofuranyl]-6-aminopurine Riboside, an A1 Adenosine Receptor Agonist, Antagonizes Catecholamine-Induced Lipolysis without Cardiovascular Effects in Awake Rats
Elevated serum nonesterified free fatty acid (NEFA) concentrations are detrimental to both the mechanical and electrical function… 
Review
2002
Review
2002
CVT-510 (CV Therapeutics).
CVT-510, the lead compound from a series of selective adenosine A1 receptor agonists, is being developed by CV Therapeutics for… 
2000
2000
CVT-510 successfully terminates paroxysmal supraventricular tachycardia,
  • 2000
  • Corpus ID: 195139875
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)